Breast Cancer Detection and Diagnosis

Risk Factors & Screening - Early Bird Catches

• Key Risks: ↑Age, BRCA1/2 genes, 1st-degree relative with breast Ca, dense breasts, prior chest RT (Radiation Therapy).
• Hormonal/Lifestyle: Early menarche (<12y), late menopause (>55y), nulliparity, prolonged HRT, obesity, alcohol.
• Screening (Mammography - Average Risk):
  • Age 50-74 yrs: Biennial.
  • Age 40-49 yrs: Individualized decision; consider annually/biennially.
• High Risk: Earlier screening (e.g., from age 25-30), often + annual MRI.

⭐ Women with BRCA1 mutation have a ~55-72% lifetime risk of breast cancer; BRCA2 mutation carriers have a ~45-69% risk by age 80.

Mammography Magic - X‑ray Vision Quest

• Low-dose X-ray imaging for breast cancer screening & diagnosis.
• Standard Views:
  • Craniocaudal (CC): Superior-inferior compression.
  • Mediolateral Oblique (MLO): Medial-lateral compression, angled for axillary tail; shows most tissue.
• Key Malignancy Signs:
  • Masses: Irregular shape, spiculated margins, high density.
  • Calcifications: Pleomorphic, fine linear/branching, clustered/segmental distribution.
  • Architectural Distortion: Parenchyma distortion without a visible mass.
  • Asymmetry: Focal, developing.
• Digital Breast Tomosynthesis (DBT/3D): Improves cancer detection, reduces recall rates.
• Findings reported using BI-RADS (Breast Imaging Reporting and Data System).

⭐ Spiculated margins of a mass are highly suggestive of malignancy (PPV ~90%).

Ultrasound & MRI - Probing Deeper

• Ultrasound (USG):
  • Role: Differentiates cystic/solid lesions; guides biopsy; adjunct in dense breasts. Key for BI-RADS assessment.
  • Malignant signs: Irregular shape, non-circumscribed (spiculated, angular, microlobulated) margins, hypoechoic, posterior shadowing, taller-than-wide.
  • Benign signs: Oval/round, circumscribed margins, anechoic (simple cysts), posterior enhancement.
  • Doppler: Assesses vascularity, often ↑ in malignancy.
• Breast MRI:
  • Indications: High-risk screening (BRCA, >20% lifetime risk), staging (disease extent), problem-solving (occult cancer), NACT response.
  • Technique: Pre/post-contrast T1W (fat-sat), T2W, DWI. Gadolinium crucial for DCE-MRI.
  • DCE kinetics (BI-RADS MRI):
    • Type I (Progressive): Usually benign.
    • Type II (Plateau): Suspicious.
    • Type III (Washout): Highly suspicious for malignancy.

  ⭐ MRI is the most sensitive modality for detecting invasive breast cancer, especially in dense breasts and for lobular carcinoma.

BI‑RADS Blueprint - Code Red or Green?

• BI-RADS (Breast Imaging Reporting and Data System) provides a universal language for breast imaging, standardizing mammography, ultrasound, and MRI report conclusions and recommendations.
• Its 7 assessment categories (0-6) are pivotal, directly dictating patient management: from additional evaluation or routine screening to biopsy and confirmed malignancy treatment.

⭐ BI-RADS 3 (Probably Benign) lesions have a <2% risk of malignancy; typically managed with short-term (e.g., 6-month) follow-up, avoiding unnecessary immediate biopsies.

Tissue Tells Tales - Biopsy Truths

• Definitive diagnosis: BI-RADS 4, 5 lesions.
• Core Needle Biopsy (CNB): Gold standard. 14G needle, 3-5 cores. Image-guided (USG, Stereo, MRI).
  • Histology: invasive vs. in-situ.
• FNAC (Fine Needle Aspiration Cytology): Limited (axillary nodes, cysts). Cannot differentiate DCIS/IDC.
• VAB (Vacuum-Assisted Biopsy): Microcalcifications, small lesions. Larger samples.
• Specimen: Formalin. Test ER/PR/HER2.

⭐ CNB is preferred over FNAC for initial diagnosis of suspicious breast masses for accuracy and invasiveness assessment.

High‑Yield Points - ⚡ Biggest Takeaways

• Mammography is the primary screening tool, detecting microcalcifications (esp. pleomorphic for DCIS) and masses.
• BI-RADS standardizes reporting, guiding management from benign (BI-RADS 2) to malignant (BI-RADS 5).
• Ultrasound differentiates cystic vs. solid masses, assesses axillary nodes, and guides biopsies.
• Breast MRI is superior for high-risk screening, implant assessment, and occult primary detection.
• IDC, the most common invasive cancer, often presents as a spiculated mass; Triple Assessment is crucial for diagnosis.